Itopride HCl
Product Description
KUKJEON
-
KR
-
2020On CPHI since
-
100 - 249Employees
Company types
KUKJEON
-
KR
-
2020On CPHI since
-
100 - 249Employees
Company types
More Products from KUKJEON (1)
-
Product Nafamostat mesylate
Nafamostat mesylate is a treatment for anticoagulant for acute pancreatitis that has shown steady growth since it was released domestically in 2004.It was mainly used in several Asian countries and recorded sales of 14.4 billion won in Korea in 2019. Our company has registered KDMF for the first time ...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance